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INFORMED CONSENT IN HEALTH RESEARCH: CHALLENGES 
AND BARRIERS IN LOW-AND MIDDLE-INCOME COUNTRIES 
WITH SPECIFIC REFERENCE TO NEPAL 
ABSTRACT  
Obtaining ‘informed consent’ from every individual participant involved in a 
health research is a mandatory ethical practice. Informed consent is a process 
whereby potential participants are genuinely informed about their role, risk 
and rights before they are enrolled in the study. Thus, ethics committees in 
most countries require ‘informed consent form’ as part of an ethics application 
which is reviewed before granting research ethics approval. Despite a 
significant increase in health research activity in low-and middle-income 
countries (LMICs) in recent years, only limited work has been done to address 
ethical concerns. Most ethics committees in LMICs lack the authority and/or 
the capacity to monitor research in the field. This is important since not all 
research, particularly in LMICs region, complies with ethical principles, 
sometimes this is inadvertently or due to a lack of awareness of their 
importance in assuring proper research governance. With several examples 
from Nepal, this paper reflects on the steps required to obtain informed 
consents and highlights some of the major challenges and barriers to seeking 
informed consent from research participants. At the end of this paper, we also 
offer some recommendations around how can we can promote and implement 
optimal informed consent taking process. We believe that paper is useful for 
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researchers and members of ethical review boards in highlighting key issues 
around informed consent. 
Keywords: ethics, research, informed consent, vulnerable population, low-and 
middle-income countries, Nepal 
INTRODUCTION 
The international bioethics guidance on health research was initiated with the 
Nuremberg Code
1
 and is enshrined in the Declaration of Helsinki (1964) 
including its most up-to-date revision.
2
 Thus, ensuring full compliance of 
ethical principles in population-health research is not a new concept. With the 
growth of health research (both observational and clinical) in low- and middle- 
income countries (LMICs), associated ethical issues have increasingly 
becoming a matter of public and scholarly debate.
3
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Earlier principles such as those in The Declaration of Helsinki (1964) were 
dominated by physician-oriented clinical research but were silent on ethical 
issues related to observational studies in LMICs. Ethical issues raised by 
health and social care research in LMICs are part of a growing literature. For 
example, the Nuffield Council on Bioethics in 2002 (The Ethics of Research 
Related to Healthcare in Developing Countries) has been an important 
resource for policymakers and researchers.
4
 Research in most LMICs is now 
overseen by an autonomous body, including Ethical Review Boards (ERBs) or 
Institutional Review Communities (IRCs). In a LMIC like Nepal with a short 
history of scientific research, a national body called Nepal Health Research 
Council (NHRC) established in 1991 approved its first National Ethical 
Guidelines for Health Research in 2001. Although few health research 
activities in Nepal started in the early 1950, they were monitored by 
Government of Nepal through Nepal Medical Research Committee.
5
 At 
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Teijlingen & P. Simkhada. Failure to apply for ethical approval for health 
studies in low-income countries. Nepal J Epidemiol  2015; 5: 511-515. 
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Nepal. Dev World Bioeth 2016. 
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present, all health-related research conducted in Nepal should be approved by 
the NHRC or IRC.
6
 
Ethics often involve a balance between respecting an individual’s 
liberty/autonomy and the ability to gain benefits for society (i.e. the greater 
good). Traditionally, specific ethics principles have been formulated based on 
the four foundation principles: a) respect for autonomy; b) non-maleficence; c) 
beneficence and; d) justice.
7
 Building on these, Vanclay and colleagues
8
 have 
recently proposed 18 principles for ethical social research. However, despite 
the importance of these principles, many researchers in LMICs do not always 
practise and implement research ethics and principles. Recently, van 
Teijlingen and Simkhada
9
 highlighted five possible reasons for not applying 
an ethical approval in low income countries: a) researchers’ perceptions that 
they do not need ethical approval; b) lack of researchers’ familiarity with the 
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for Health Research in Nepal and Standard Operating Procedures. 
Kathmandu: Nepal Health Research Council. 
7
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ethics committee; c) researchers applying to the wrong authority; d) time and 
resource constraints; and e) assumptions that non-clinical research is 
exempted. In a recent paper, Sharma and colleagues (2016)
10
 further argue that 
research designed to generate evidence for programmatic interventions is not 
always registered in Nepal, due to the lack of a clear definition as to what is 
regarded as health research, making it more difficult for ethical bodies to 
monitor the overall volume of research activities in their country. Perhaps 
more importantly, when research does not comply with key ethical principles, 
it may not fully protect the dignity, rights, safety and well-being of its 
participants. Simultaneously, such work may not assure effective 
communication with participants which could mean consent decisions being 
made on poor or even false information. Furthermore, such research can be 
more difficult to publish in high-quality academic journals which often 
mandate that the research they published has been granted ethical approval. 
The International Committee of Medical Journal Editors (ICMJE) guideline, 
for example, requires ethical approval for any health-related research 
involving humans.
11
 
‘Informed consent’ is a popular and universal benchmark concept and 
mechanism for addressing ethical issues in clinical or public health research, 
and an important element in conducting research ethically. The focus on 
informed consent falls firmly into the fundamental arena of respect for the 
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autonomy of participating individuals, one of the four key ethical principles.
12
 
However, informed consent procedures and research ethics are sometimes not 
given the due attention and care both by the participants and the researchers in 
LMICs. Riessman (2005) noted that it was difficult to implement informed 
consent during her study on 'female infertility' in rural villages of India 
because the participants assume the consent form was a government 
document.
13
 Moreover even after providing written consent they are not aware 
of it in a real sense. It is often very difficult to uphold confidentiality during 
the interview process due to frequent interference of family members. The 
latter was also noted in focus group studies in rural Nepal, where 
confidentiality was hard to maintain as it can be culturally and physically 
difficult to keep non-participants away.
14
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Box 1: Informed consent in practice
15
 
 
Informed consent means that all research participants have received adequate 
information about the research, enabling them to choose freely whether they 
wish to be involved or not. However, during the field survey such 
communication between researchers and potential research participants is not 
always perfect. Consequently, research participants may not always fully 
understand their role, rights and risks (3R) of taking part in the research. 
Researchers studying the comprehension of informed consent among clinical 
trial participants reported that participants both from high- and low- income 
countries exhibited limited understanding or even misunderstanding about the 
concept.
16
 This misunderstanding is more frequent in LMICs because local 
research volunteers are more likely to be illiterate and unaware of ethical 
principles of research. In this paper, we highlight the challenges in adhering to 
                                                          
15
 World Healh Organization. 2015. Global health ethics: key issues. Geneva: 
World Health Organization. 
16
 D.W. Fitzgerald, C. Marotte, R.I. Verdier, W.D. Johnson & J.W. Pape. 
Comprehension during informed consent in a less-developed country. Lancet 
2002; 360: 1301-1302. 
The researcher has to make sure that the subject’s participation is fully informed on: 
 what the study is about,  
 what its risks and benefits are 
 how the results will be used,  
 the fact that participation is voluntary and  
 can be stopped at any time  
 identity will be protected 
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ethical procedures and taking fully informed consent in LMICs, with examples 
from Nepal.  
VERBAL VERSUS WRITTEN CONSENT: A DILEMMA 
 Although some regulations require evidence of consent from the research 
participants, which in most cases is the signed consent form, these practices 
however should be adopted carefully. Health research is often conducted with 
different population groups or subgroups and not everyone is capable of 
giving written consent. For example, people with limited literacy and young 
children are unlikely to be able to read the study information sheet and sign 
the consent form. In the case of a minor (say someone under the age of 12 or 
in some countries under the age of 16), the use of parental consent is 
commonly taken as a proxy. Furthermore, a lack of clear guidance in most 
LMICs on the consent taking procedure poses further challenges to being able 
to adherence to ethics principles. One example is that despite stating clearly 
around importance of informed consent and its process to ensure it is 
voluntary, the NHRC/IRC guideline
17
 for Nepal is silent about verbal or 
written consenting methods raising ambiguity in the process. The context in 
which verbal or written consent is appropriate should be clearly informed by 
NHRC guidance.  
Researchers working with vulnerable or socially disadvantaged groups or 
those with lower literacy may ask potential participants to write their name or 
signatures. However, such public record may in practice result in a breach of 
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 Nepal Health Research Council, op. cit. Note 6. 
9 
 
confidentiality. Use of thumb prints for illiterate participants as an alternative 
also has certain disadvantages such as some studies have reported that the 
participants may think this may have legal implications
18
 or that they could be 
deceived, which may in turn develop mistrust about the study. In such 
situations where written consent is not possible and plausible, witnessed 
consent from an independent individual would be a better alternative. The 
reason for undertaking witnessed consent should be recorded and the person 
seeking the consent must be able to show ethical considerations. 
Ideally, a 'participant information sheet' must be provided to all research 
participants in advance offering sufficient time to consider the decision 
regarding their participation before requesting formal consent. The 
information sheet should be provided in the participant’s local language or in 
the language the participant is most comfortable with. The information sheet 
should clearly explain the key aspects of the research: background to the 
study, aim and objectives, potential participants of the study, possible risks 
and benefits of the research or experiments (both direct and indirect), 
incentives, risks and benefits of other options (including not getting 
treatment), opportunity to ask questions, information that would enable 
participants to make a decision, contacts details of the researchers including 
ethical approval boards and right to refuse from the participation and 
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 P. A. Marshall. 2007. Ethical Challanges in Study Design and Informed 
Consent for Health Research in Resource-Poor Setting. Geneva: World Health 
Organization. 
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withdrawal from the research at any time (i.e. complying with the Declaration 
of Helsinki
19
). Researchers’ skills are particularly important in communicating 
the importance of the research and describing its aims and objectives, 
including the potential risk and benefit to the research participants. This 
necessitates that research capacity building activities (e.g. training, 
workshops), that to date have mostly focused on familiarization of research 
tools or data collection approach, should offer experiential learning 
approaches to strengthen researchers’ skills. 
LOCAL LANGUAGE IN A RESEARCH: OPPORTUNITY OR 
BARRIER? 
As health sector research or services delivery in LMICs are heavily dependent 
on external funding
20
, much of their research is likely to be collaborative in 
nature where English language (or any other former colonial language) is 
commonly used between research implementing partners and funding 
agencies. It is a common practice for researchers from LMICs to draft research 
protocols, tools used such as questionnaires and consent forms in English. 
Where documents are initially prepared in a language other than that of the 
research participants, those documents should be translated into the given 
local (vernacular) language and validated. The latter can be done by doing 
back translation into English by an independent translator in order to make 
sure the original meaning is not lost during the translation phase. There may 
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be financial and time implications validating such translations,
21
 but providing 
information about the research in participants' preferred languages may have a 
multiple benefits including free expression.
22
 For example in countries as 
diverse as Nepal, local languages are often preferred in terms of both culture 
and linguistics. However, it is not always easy to carry out research among 
some ethic groups or indigenous populations (IP) as their traditional culture or 
language can be barriers. Limited literature on IP reflects that IP have often 
little or no representation or rights with respect to the research process, or the 
interpretation and use of the resulting data. Therefore, research needs of IP and 
ethics groups should be explored, after such exploration research should be 
organized, designed and conducted in a manner that takes account of cultural 
differences.
23
 
LEGAL AGE TO CONSENT 
The threshold of the age of consent is another contentious area. Alderson 
(2007) argues that research which could equally well be done with adults 
should never be undertaken with children,
24
 but this is not always possible. 
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 H.J. Smith, J. Chen & X. Liu. Language and rigour in qualitative research: 
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24
 Alderson, op. cit. Note 1. 
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The statutory age of consent to treatment or being involved in a research 
varies considerably between countries from 12 to 19.
25
 Although consent 
involves evaluating risks and considering whether to undertake them, for self-
evident practical reasons research participants such as children may not 
understand the risk involved in taking part in a research. There could be extra 
risks as children tend to be more vulnerable than adults for being harmed in 
the short or long term by interventions.
26
 Children are generally less likely to 
resist and often more likely to respond to researchers’ requests. In Nepal, for 
example, there is a practice of taking guardians' or parents' consent if research 
involves children. A clear threshold age of consent has not been recommended 
in NHRC guidelines. However, we have observed that most of the researchers 
in Nepal consider age 16 years and above as a threshold to solicit informed 
consent as it is a legal age to obtain Nepalese citizenship and to enroll in a 
voter roll.  This practice based on legal standard is inconsistent with the 
evidence from other settings which showed that participants aged 14 years or 
more have an equal competency to provide informed consent as in the adults. 
27
Thus, it would be useful to explore the relationship between age and 
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552. 
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competency among children and minors in Nepal based on key capabilities 
required to provide informed consent such as to what extent they understand 
research, assess risks and benefits, and possess decision making skills. This 
would also be in line with the Article 12 of the 'United Nations Conventions 
on the Right of the Child' which clearly states that child's participation in the 
decision making process should be appropriate to their level of maturity.
28
 We, 
therefore, recommend NHRC, the research governing body of Nepal, to act on 
determining evidence based threshold age of consent. Although parents or 
guardians with legal responsibility should be consented for the children 
incompetent to consent, children themselves should also be asked for their 
consent appropriately and in a transparent way with witnesses and records of 
the consent taking process should be kept. It is advisable to inform young 
children about the research and/or interventions before obtaining their consent 
by preparing and sharing imaginative leaflets, videos or explanatory toys. 
However, in the context of research among the most at-risk populations such 
as sex workers, or drug misusers, there is a greater chance of such child-
participants being discriminated against or even rejected by their families, 
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particularly in LMICs if the research makes their status as a sex worker or 
drug user common knowledge. 
INFLUENCE ON DECISION MAKING 
In most LMICs, the response rates are often quite high, in some cases up to 
100%. High response rate could be due to a number of reasons, such as (i) 
there is very little research taking place in LMIC, especially in rural areas, 
therefore participants might get involved due to their curiosity or they may 
even be pleased to be invited to participate; (ii)  direct or indirect involvement 
of local health care workers or community health volunteers (such as female 
community health volunteers in Nepal), who have a very influential role in the 
diagnosis/treatment of common non-serious diseases in the locality. Support 
from locally well-regarded individuals such as the elders, teachers and 
community leaders might also contribute in high response rates. There is also 
a notion that in LMICs, researchers are generally of higher socio-economic 
status and this socio-economic inequality leads the participants to feel that 
they are obliged to participate in a study when requested.
29
 In clinical research, 
some individuals participate in the research with the aim of getting their health 
checked for free as they cannot afford expensive medical screening. It may be 
also possible that they take part in interventional studies because the 
treatments are provided free of cost. Some researchers provide financial 
incentives or compensate for the time of participants to increase the response 
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 S.R. Benatar. Reflections and recommendations on research ethics in 
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rates. Equally, it may be true that participants develop a relationship of trust 
with researchers and they participate in order to help the research to move 
forward but these could be limited to those participants with a higher 
educational status.  
As in many LMICs, health research in Nepal has increased drastically in the 
last few decades. One of the most important research ethics principles is 
‘autonomy’ and gender is often an important determinant of such autonomous 
decision-making processes. Acharya and colleagues
30
 highlighted that women, 
particularly the uneducated women in Nepal, have less power and autonomy in 
household level decision-making compared to men. The practices where 
spousal permission and company are needed in order to visit a health clinic for 
a diagnosis or treatments have been documented.
31
 In such situations where 
women require a permission from their husbands or other family members to 
be allowed to participate in health research. This raises the question; to what 
extent are women (a) informed and able to offer informed consent; and (b) 
whether they can culturally choose not to consent once their husband has 
given permission for her research participation. Currently, research on 
                                                          
30 D.R. Acharya, J.S. Bell, P. Simkhada, E.R. van Teijlingen & P.R. Regmi. 
Women's autonomy in household decision-making: a demographic study in 
Nepal. Reprod Health 2010; 7: 15. 
31 B. Gyawali, J.J. Keeling, E. van Teijlingen, L. Dhakal & A.R. Aro. Cervical 
cancer screening in Nepal: Ethical considerations. Medicoleg  Bioeth 2015: 1-
6. 
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autonomy or the decision-making power of different genders in relation to 
their participation in a health research is lacking. Other possible biases in 
decision-making may arise when a health facility/hospital or health 
professionals are themselves directly involved in the research. It is the duty of 
researchers to convey to the participants by means of the informed consent 
that the decision on whether to participate or not will not have any 
consequence for their ongoing or future service from the health care facility, 
and that they are free to withdraw from the research at any time and without 
providing any reason whatsoever. Moazam and Jafarey
32
 opined that socially 
and culturally entrenched norms and Islamic laws have a greater influence on 
bioethics in Pakistan. 
RISKS AND BENEFITS 
The primary aim of the health research is to benefit the population or its sub-
section either immediately or in the future and general guiding principle is that 
the benefits should always outweigh the risks. Some participants might ask 
'what beneficial outcome am I going to get if I take part in this research?' The 
researcher should be able to apprise the participants on the benefit that their 
participation may confer in the future in due course. In Nepal, providing the 
findings of the research to a local health authority such as a district health 
office would demonstrate benefit to the participating community. As an 
immediate benefit, we do not recommend any monetary incentive to the 
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participants but where appropriate, people should be reimbursed for their 
travel costs. However, providing other forms of incentive related to the 
research area, e.g. providing dietary supplements in research on maternal and 
child health or condoms to sexually active populations, could be acceptable.  
The issue of potential risks particularly involving biological specimens (e.g. 
blood, sputum and urine) and the use of medical devices are important and to 
be discussed in advance, a clear plan to minimize the risks should be listed. 
Participants who suffer injuries during the research, even minor ones (i.e. 
finger-pricked for blood sample) should be dealt with caution and a log of all 
accidents should be kept up to date. The participants should be informed in 
advance on any potential risk such as inflammation or pain. Despite a very 
rare probability of potential risk, participants should be clearly informed about 
it a priori. Potential risks need to be fully described (e.g. in the research 
information sheet, consent form) and discussed with all potential study 
participants prior to participation. It should clearly mention the contact person 
and reporting procedures in case of any social or physical harm that may arise 
as a result of taking part in the study. Research staff should be aware and 
trained with appropriate counselling skills to refer such participants to services 
within their communities. An account of potential social harm outcomes 
resulted from the participation during research also need to be appropriately 
reported to all relevant ERBs and IRCs.  
18 
 
In addition, psycho-social risks (e.g. emotional responses to a research topic) 
may occur to participants in social studies or research in sensitive issues.
33
 
There are also good reasons not to underestimate the importance of emotional 
and social risks. If researchers feel some questions may cause psycho-social 
risk to the participants due to individual circumstances, it would be beneficial 
to discuss a priori with local research staffs. This is the responsibility of the 
researcher to describe eloquently and in unambiguous ways, their protocol and 
in the script of the consent form ensuring whether it is done or not, may fall 
under the remit of the ERBs and peer reviewers that should be mentioned in 
the guidelines. If an application fails to address the issues, the reviewers 
should ask the researchers to address the questions clearly. 
A WAY FORWARD 
Research participants from LMICs such as in Nepal, can comprehend a 
consent-taking process if sufficient information is provided by the researchers 
in demonstrably clear and easy to understand ways. We suggest that ways of 
informing children, populations at risk and indigenous people, respecting their 
autonomy and their vulnerability, to help to fulfil the longstanding guidance 
that ‘research involving these vulnerable populations is important for the 
benefit of participants'. Incorporating ‘ethics training’ in postgraduate and 
public health training programs would help to explain the importance and 
                                                          
33 M.M. Burgess. Proposing modesty for informed consent. Soc Sci Med 2007; 
65: 2284-2295. 
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maintain the adherence fully informed consent and ethics in research. The 
following suggestions are therefore made to indicate ways forward: 
 Researchers must ensure that the informed consent-taking process is 
conducted appropriately and detailed information about risks and 
benefits are provided to participants in easily understood ways.  
 Having participated in the research and assumed risks, the participants 
and host community have a right to know what was found and its 
implications for public health and social-care policies. Publishing in 
Open Access journals which are available free of cost to read on the 
web, increases the chance that someone in LMICs can read your 
research findings, but English language would still be a barrier, 
particularly to those living in the rural communities. 
 Ethical review boards should ensure all research subjects are at 
minimum or low risk. ERBs’ responsibilities include protecting 
potential research participants from undue pressure or coercion that 
could be used on them to take part in a study and play a key role in 
preventing distortion of recruitment, particularly by imposing tight 
restrictions on how participants may be approached.  
 Health research councils should act to determine evidence based 
threshold age of consent and discourage current practice of considering 
legal standard. 
 Research funders and collaborators should ensure that research in host 
countries is conducted in compliance with the requirements laid out by 
local ERBs. 
20 
 
Finally, we have a notion that only properly conducted consent process 
respects the autonomy and fundamental human rights of a study participant, 
including freedom from explicit or implicit exploitation. It also protects 
researchers from criticisms, complaints, mitigation; and participants from any 
risk during the recruitment and participation phases. This paper is hopefully of 
use to researchers in LMICs as well as members of ethical review boards in 
highlighting key issues around informed consent.  
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